Table 2.
Demographic and clinical characteristics of study populations at baseline
| Methoxyflurane (n=102) | Placebo (n=101) | N2O (n=30) | Placebo (n=30) | |
|---|---|---|---|---|
| Age (years) | 35 (18–74) | 30 (18–84) | 37 (26–66) | 29 (23–50) |
| Male sex | 53 (52%) | 51 (50.5%) | 20 (67%) | 19 (63%) |
| Trauma site | ||||
| Upper limb | 21 (20.6%) | 37 (36.6%) | 11 (37%) | 8 (27%) |
| Lower limb | 60 (58.8%) | 57 (56.4%) | 12 (40%) | 15 (50%) |
| Back | 5 (4.9%) | 2 (2%) | 6 (20%) | 7 (23%) |
| Chest | 8 (7.8%) | 0 | 1 (3%) | 0 |
| Other | 8 (7.8%) | 5 (5%) | 0 | 0 |
| Pain intensity | 68 (25–100)a | 70 (10–100)a | 6 (5–6)b | 6 (5–6)b |
Notes:
a
Visual analog scale (0 = no pain to 100 = worst pain);
b
numeric rating scale (0 = no pain to 10 = worst imaginable pain). Data are median (range) or number of patients (%).